Mesenchymal stem cell function on hybrid organic/inorganic microparticles in vitro

Journal of Tissue Engineering and Regenerative Medicine

Volumn 4, Issue 5, 2010, Pages 340-348

  Jayasuriya, A Champa ^a   Bhat, Archana ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Gene expression; Hybrid microparticles; Injectable; Mesenchymal stem cells; Osteoblasts; Proliferation

Indexed keywords

BONE; CALCITE; CALCIUM CARBONATE; CALCIUM PHOSPHATE; CELL CULTURE; CELL PROLIFERATION; OSTEOBLASTS; PHOSPHATASES; POLYMERASE CHAIN REACTION; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE REGENERATION;

BONE REGENERATION; CELL FUNCTIONS; GENES EXPRESSION; HYBRID MICROPARTICLE; HYBRID ORGANIC-INORGANIC; INJECTABLES; INORGANIC MICROPARTICLES; MESENCHYMAL STEM CELL; MICRO PARTICLES; PROLIFERATION;

GENE EXPRESSION;

ALKALINE PHOSPHATASE; CALCIUM CARBONATE; CALCIUM PHOSPHATE DIBASIC; CHITOSAN; COLLAGEN TYPE 1; INORGANIC COMPOUND; MESSENGER RNA; ORGANIC COMPOUND; OSTEOCALCIN; TRIPOLYPHOSPHATE;

ANIMAL CELL; ARTICLE; BONE REGENERATION; CELL FUNCTION; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

EID: 77954269664     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.244     Document Type: Article

References (47)

1. Arpornmaeklong P, Suwatwirote N, Pripatnanont P, et al. 2007; Growth and differentiation of mouse osteoblasts on chitosan-collagen sponges. Int J Oral Maxillofac Surg 36: 328-337.
2. Bucholz RW. 2002; Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 395: 44-52.
3. Boyce T, Edwards J, Scarborough N. 1999; Allograft bone: the influence of processing on safety and performance. Orthop Clin North Am 30: 571-581.
4. Burg KJ, Poter S, Kellam JF. 2000; Biomaterial developments for bone tissue engineering. Biomaterials 21: 3247-2359.
5. Burkatovskaya M, Tegos GP, Swietlik E, et al. 2006; Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice. Biomaterials 27: 4157-4164.
6. Chesnutt BM, Viano AM, Yuan Y, et al. 2009; Design and characterization of a novel chitosan/nanocrystalline calcium phosphate composite scaffold for bone regeneration. J Biomed Mater Res A 88: 491-502.
7. Conti B, Giunchedi P, Genta I, et al. 2000; The preparation and in vivo evaluation of the wound-healing properties of chitosan microspheres. STP Pharma Sci 10: 101-104. (Pubitemid 30126793)
8. Cowles EA, DeRome ME, Pastizzo G, et al. 1998; Mineralization and the expression of matrix proteins during in vivo bone development. Calcif Tissue Int 62: 74-82. (Pubitemid 28018679)
9. Di Martino A, Sittinger M, Risbud MV. 2005; Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26: 5983-5990. (Pubitemid 40805604)
10. Friedlander GE. 1987; Currents concepts review: bone grafts: the basic science rationale for clinical applications. J Bone Joint Surg 69A: 786-790.
11. Goldstein SA. 2006; Tissue engineering solutions for traumatic bone loss. J Am Acad Orthop Surg 14(10 suppl): S152-156.
12. Griffith LG. 2002; Emerging design principles in biomaterials and scaffolds for tissue engineering. Ann NY Acad Sci 961: 83-95.
13. Hoemann CD, Sun J, Legare A, et al. 2005; Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthr Cartilage 13: 318-329. (Pubitemid 40361575)
14. Huihua Fu, Bruce Doll, Tim McNelis. 2007; Osteobalst differentiation in vitro and in vivo promoted by osterix. J Biomed Mat Res Part A 83: 770-778. (Pubitemid 350086303)
15. Ishaug-Riley SL, Crane GM, Miller MJ, et al. 1997; Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 36: 17-28.
16. Jayasuriya AC, Bhat A. 2009a; Optimization of scaled-up chitosan microparticles for bone regeneration. Biomed Mater 4: 55006.
17. Jayasuriya AC, Bhat A. 2009b; Fabrication and characterization of novel hybrid organic/inorganic microparticles to apply in bone regeneration. J Biomed Mater Res A 2009 Oct 13 (Epub ahead of print).
18. Jayasuriya AC, Gallagher SP, Shin K, et al. 2003; Development of environmentally responsive micro porous poly(lactide-co-glycolide) scaffolds for bone tissue engineering. Trans. Soc Biomater 29: 637.
19. Jayasuriya AC, Shah C. 2008; Controlled release of insulin-like growth factor-1 and bone marrow stromal cell function of bone-like mineral layer-coated poly(lactic-co-glycolic acid) scaffolds. J Tissue Eng Regen Med 2: 43-49.
20. Kato Y, Onishi H, Machida Y. 2003; Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol 4: 303-309. (Pubitemid 37220862)
21. Khan Y, Yaszemski MJ, Mikos AG, et al. 2008; Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am 90(suppl 1): 36-42.
22. Kong L, Ao Q, Wang A, et al. 2007; Preparation and characterization of a multilayer biomimetic scaffold for bone tissue engineering. J Biomater Appl 22: 223-239.
23. Kruyt MC, Persson C, Johansson G, et al. 2006; Towards injectable cell-based tissue-engineered bone: the effect of different calcium phosphate microparticles and preculturing. Tissue Eng 12: 309-317.
24. Lahiji A, Sohrabi A, Hungerford DS, et al. 2000; Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res 51: 586-595. (Pubitemid 30450717)
25. Latta LL, Sarmiento A, Zych GA. 2003; Principles of nonoperative fracture treatment. In Skeletal Trauma: Basic Science, Management, and Reconstruction, 3rd edn, Browner BD, Jupiter JB, Levine AM, et al. (eds). Saunders: Philadelphia, PA; 159-194.
26. Leong DT, Gupta A, Bai HF, et al. 2007; Absolute quantification of gene expression in biomaterials research using real-time PCR. Biomaterials 28: 203-210. (Pubitemid 44537394)
27. Li Z, Ramay HR, Hauch KD, et al. 2005; Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomat 26: 3919-3928. (Pubitemid 40038783)
28. Li Z, Yubao L, Aiping Y, et al. 2005; Preparation and in vitro investigation of chitosan/nano-hydroxyapatite composite used as bone substitute materials. J Mater Sci Mater Med 16: 213-219. (Pubitemid 40386274)
29. Lee JY, Choo JE, Park HJ, et al. 2007; Injectable gel with synthetic collagen-binding peptide for enhanced osteogenesis in vitro and in vivo. Biochem Biophys Res Commun 357: 68-74.
30. Lee YM, Park YJ, Lee SJ, et al. 2000; Tissue engineered bone formation using chitosan/tricalcium phosphate sponges. J Periodontol 71: 410-417.
31. Lohmann H, Grass G, Rangger C, et al. 2007; Economic impact of cancellous bone grafting in trauma surgery. Arch Orthop Trauma Surg 127: 345-348.
32. Ludwig SC, Kowalski JM, Boden SD. 2000; Osteoinductive bone graft substitutes. Eur Spine J 9(suppl 1): S119-125.
33. Maniatopoulos C, Sodek J, Meleher AH. 1988; Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254: 317-330.
34. Moerman EJ, Teng K, Lipschitz DA, et al. 2004; Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-γ 2 transcription factor and TGF-β/BMP signaling pathways. Aging Cell 3: 379-389.
35. Ohgushi H, Miyake J, Tateishi T. 2003; Mesenchymal stem cells and bioceramics: strategies to regenerate the skeleton. Novartis Found Symp 249: 118-127.
36. Orienti I, Cerchiara T, Luppi B, et al. 2002; Influence of different chitosan salts on the release of sodium diclofenac in colon-specific delivery. Int J Pharm 238: 51-59.
37. Owen TA, Aronow M, Shalhoub V, et al. 1990; Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143: 420-430.
38. Portero A, Remunan-Lopez C, Criado MT, et al. 2002; Reacetylated chitosan microspheres for controlled delivery of antimicrobial agents to the gastric mucosa. J Microencap 19: 797-809. (Pubitemid 36149840)
39. Rees DC, Haddad FS. 2003; Bone transplantation. Hosp Med 64: 205-209.
40. Seol YJ, Lee JY, Park YJ, et al. 2004; Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett 26: 1037-1041. (Pubitemid 38852350)
41. Silber JS, Anderson DG, Daffner SD, et al. 2003; Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 28: 134-139. (Pubitemid 36110079)
42. Wang J, de Boer J, de Groot K. 2008; Proliferation and differentiation of MC3T3-E1 cells on calcium phosphate/chitosan coatings. J Dent Res 87: 650-654.
43. Xu JW, Zaporojan V, Peretti GM, et al. 2004; Injectable tissue-engineered cartilage with different chondrocyte sources. Plast Reconstr Surg 113: 1361-1371. (Pubitemid 39201866)
44. Xu HH, Quinn JB, Takagi S, et al. 2004; Synergistic reinforcement of in situ hardening calcium phosphate composite scaffold for bone tissue engineering. Biomaterials 25: 1029-1037. (Pubitemid 37393294)
45. Younger EM, Chapman MW. 1989; Morbidity at bone graft donor sites. J Orthop Trauma 3: 192-195.
46. zur Nieden NI, Kempka G, Ahr HJ. 2003; In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71: 18-27.
47. Zhang Y, Ni M, Zhang M, et al. 2003; Calcium phosphate-chitosan composite scaffolds for bone tissue engineering. Tissue Eng 9: 337-345. (Pubitemid 36944183)